Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography

por Kasamon, Yvette L.
Publicado 2011

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma

por Kasamon, Yvette L., de Claro, R. Angelo, Wang, Yaping, Shen, Yuan Li, Farrell, Ann T., Pazdur, Richard
Publicado 2017

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

por Munchel, Ashley, Kesserwan, Chimen, Symons, Heather J., Luznik, Leo, Kasamon, Yvette L., Jones, Richard J., Fuchs, Ephraim J.
Publicado 2011

FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma

por Richardson, Nicholas C., Kasamon, Yvette L., Chen, Haiyan, de Claro, R. Angelo, Ye, Jingjing, Blumenthal, Gideon M., Farrell, Ann T., Pazdur, Richard
Publicado 2019

FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis

por Kasamon, Yvette L., Ko, Chia‐Wen, Subramaniam, Sriram, Ma, Lian, Yang, Yuching, Nie, Lei, Shord, Stacy, Przepiorka, Donna, Farrell, Ann T., McKee, Amy E., Pazdur, Richard
Publicado 2018